

TECHNOLOGY
Autonomous, hands-free ultrasound
Bloom Standard’s RAPIDscan Ultrasound System has received FDA Breakthrough Device Designation. The Device is pending FDA approval and has not been authorized or cleared by the FDA. Investigational Device, Limited by Federal Law to Investigational Use.
01 / PROBLEM
90% of children lack access to ultrasound imaging in their local medical settings
Delayed detection of respiratory + cardiac conditions are among the most common killers of babies + children, responsible for nearly 1/3 of under-5 deaths globally.
​
Between 60-75% of these deaths could be prevented through earlier detection and rapid assessment of their condition.
Most existing newborn, pediatric and maternal ultrasound solutions are expensive, immobile and can only be used in high-level medical setting by highly skilled health staff
02 / SOLUTION
Autonomous, hands-free ultrasound scans - any user, anywhere
Simple hands free RAPID scan, to earlier detect heart or lung abnormalities in maternity, primary care, underserved, under-resourced, humanitarian and front line health settings
AI-driven onboard image interpretation = real time decision support, timely referrals, lifesaving interventions + conservation of essential health resources
03 / IMPACT
Reduce mortality and poor outcomes tied to delayed detection of lung + cardiac conditions
Bolsters health access + equity for medically fragile children
Integrates with existing health systems + public health initiatives
Ends excessive use of potentially-harmful x-ray imaging in children
10X cost savings over traditional ultrasound solutions

ABOUT BLOOM

OUR STORY
Developed by parents of a child with CHD (Congenital Heart Defect), Bloom Standard is more than just another device, it's a passion that has followed our team around the world.

OUR VISION
Saving lives by removing barriers to essential ultrasound imaging.

APPROACH
Work in tandem with NGOs + global health stakeholders to prioritize deployment into most urgent settings
Target product profiles in alignment with public health priorities and health resources
User-driven design, developed and piloted in exact use-settings
Collaboration with clinical, technical partners to accelerate adoption, optimize and expand use cases